Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial

Georges Mourad*, Maciej Glyda, Laetitia Albano, Ondrej Viklicky, Pierre Merville, Gunnar Tyden, Michel Mourad, Aleksander Lohmus, Oliver Witzke, Maarten H. L. Christiaans, Malcolm W. Brown, Nasrullah Undre, Gbenga Kazeem, Dirk R. J. Kuypers, Advagraf Based Immunosuppression

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science